Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation's Books

Assessing the Use of Agent-Based Models for Tobacco Regulation

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation

Write a review Read reviews Take a Quiz Solve Book Puzzle

Assessing the Use of Agent-Based Models for Tobacco Regulation

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation

Tobacco consumption continues to be the leading cause of preventable disease and death in the United States. The Food and Drug Administration (FDA) regulates the manufacture, distribution, and marketing of tobacco products - specifically cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco - to protect public health and reduce tobacco use in the United States. Given the strong social component inherent to tobacco use onset, cessation, and relapse, and given the heterogeneity of those social interactions, agent-based models have the potential to be an essential tool in assessing the effects of policies to control tobacco. Assessing the Use of Agent-Based Models for Tobacco Regulation describes the complex tobacco environment; discusses the usefulness of agent-based models to inform tobacco policy and regulation; presents an evaluation framework for policy-relevant agent-based models; examines the role and type of data needed to develop agent-based models for tobacco regulation; provides an assessment of the agent-based model developed for FDA; and offers strategies for using agent-based models to inform decision making in the future.

Average ratings

N/A

Write a review

Solve jigsaw puzzle

Age

Page Count

269

Publisher

National Academies Press

Published Date

ISBN 10

0309317258

ISBN 13

9780309317252

Assessing the Use of Agent-Based Models for Tobacco Regulation

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation

Write a review Read reviews Take a Quiz Solve Book Puzzle

Assessing the Use of Agent-Based Models for Tobacco Regulation

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on the Assessment of Agent-Based Models to Inform Tobacco Product Regulation

Average ratings

N/A

Write a review

Solve jigsaw puzzle

Age

Page Count

269

Publisher

National Academies Press

Published Date

ISBN 10

0309317258

ISBN 13

9780309317252

Understanding the U.S. Illicit Tobacco Market

Characteristics, Policy Context, and Lessons from International Experiences

By: National Research Council,Committee on the Illicit Tobacco Market: Collection and Analysis of the International Experience

Write a review Read reviews Take a Quiz Solve Book Puzzle

Understanding the U.S. Illicit Tobacco Market

Characteristics, Policy Context, and Lessons from International Experiences

By: National Research Council,Committee on the Illicit Tobacco Market: Collection and Analysis of the International Experience

Tobacco use has declined because of measures such as high taxes on tobacco products and bans on advertising, but worldwide there are still more than one billion people who regularly use tobacco, including many who purchase products illicitly. By contrast to many other commodities, taxes comprise a substantial portion of the retail price of cigarettes in the United States and most other nations. Large tax differentials between jurisdictions increase incentives for participation in existing illicit tobacco markets. In the United States, the illicit tobacco market consists mostly of bootlegging from low-tax states to high-tax states and is less affected by large-scale smuggling or illegal production as in other countries. In the future, nonprice regulation of cigarettes - such as product design, formulation, and packaging - could in principle, contribute to the development of new types of illicit tobacco markets. Understanding the U.S. Illicit Tobacco Market reviews the nature of illicit tobacco markets, evidence for policy effects, and variations among different countries with a focus on implications for the United States. This report estimates the portion of the total U.S. tobacco market represented by illicit sales has grown in recent years and is now between 8.5 percent and 21 percent. This represents between 1.24 to 2.91 billion packs of cigarettes annually and between $2.95 billion and $6.92 billion in lost gross state and local tax revenues. Understanding the U.S. Illicit Tobacco Market describes the complex system associated with illicit tobacco use by exploring some of the key features of that market - the cigarette supply chain, illicit procurement schemes, the major actors in the illicit trade, and the characteristics of users of illicit tobacco. This report draws on domestic and international experiences with the illicit tobacco trade to identify a range of possible policy and enforcement interventions by the U.S. federal government and/or states and localities.

Average ratings

N/A

Write a review

Solve jigsaw puzzle

Age

Page Count

316

Publisher

National Academies Press

Published Date

ISBN 10

0309317150

ISBN 13

9780309317153

Scientific Standards for Studies on Modified Risk Tobacco Products

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on Scientific Standards for Studies on Modified Risk Tobacco Products

Write a review Read reviews Take a Quiz Solve Book Puzzle

Scientific Standards for Studies on Modified Risk Tobacco Products

By: Institute of Medicine,Board on Population Health and Public Health Practice,Committee on Scientific Standards for Studies on Modified Risk Tobacco Products

Smoking-related diseases kill more Americans than alcohol, illegal drugs, murder and suicide combined. The passage of the Family Smoking Prevention and Tobacco Control Act of 2009 gave the FDA authority to regulate "modified risk tobacco products" (MRTPs), tobacco products that are either designed or advertised to reduce harm or the risk of tobacco-related disease. MRTPs must submit to the FDA scientific evidence to demonstrate the product has the potential to reduce tobacco related harms as compared to conventional tobacco products. The IOM identifies minimum standards for scientific studies that an applicant would need to complete to obtain an order to market the product from the FDA.

Average ratings

N/A